Brief: Targovax Extends Term Of IOVaxis's License Option By 3 Months
Jan 6 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX GRANTS IOVAXIS 3 MONTHS EXTENSION TO EXCLUSIVE
LICENSE
OPTION FOR TG MUTANT RAS VACCINES IN GREATER CHINA AND SINGAPORE
* DUE TO UNFORESEEN DELAYS, TARGOVAX HAS EXTENDED TERM OF
IOVAXIS'S LICENSE OPTION BY 3 MONTHS, OTHERWISE AGREEMENT
REMAINS UNCHANGED
Source text for Eikon: ID:nWkr9j3BfV
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration